Considering a molecular laboratory viewpoint, Relafen 750 (Naproxen) exhibits distinct characteristics . It works primarily as a NSAID agent, largely inhibiting cyclooxygenase-2 (COX-2), an protein implicated in prostaglandin formation. This targeted inhibition results in decreased inflammation and ache, delivering clinical advantages for individua